X4 PHARMACEUTICALS

View On IPO.GOV.AU

Protected: Registered/protected

Last updated on 13 Oct 2023

Owner Info

X4 Pharmaceuticals, Inc.

955 Massachusetts Avenue, 4th Floor

Cambridge MA 02139, UNITED STATES OF AMERICA

Serial Number

2275563 filed on 26 Jan 2022

Correspondent

Glenn A. Gundersen Dechert LLP

2929 Arch Street, Cira Centre,

Philadelphia PA 19104-2808,

UNITED STATES OF AMERICA

X4 PHARMACEUTICALS

Classification Information

2275563

26 Jan 2022

26 Jan 2032

WORD

26 Jul 2021

Status Date	Action Taken
13^th Oct 2023	International Registration in Australia Protected After Adverse (Amendments) correspondence sent
13^th Oct 2023	International Registration in Australia Protected After Adverse (Amendments) correspondence sent
3^rd Oct 2023	IP Right Registration Published
3^rd Oct 2023	Status change to Registered/Protected
26^th Jul 2023	Application Accepted correspondence sent
25^th Jul 2023	Application Accepted correspondence sent
25^th Jul 2023	IP Right has been Examined
25^th Jul 2023	IP Right Acceptance Published
25^th Jul 2023	Status change to Accepted
25^th Jul 2023	IP right goods and service classes updated